A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19)
Phase 1
- Conditions
- novel coronavirus pneumonia (COVID-19)
- Registration Number
- ITMCTR2000002952
- Lead Sponsor
- The First Hospital of He'nan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. patients with 2019-nCoV pneumonia;
2. Sign informed consent.
Exclusion Criteria
1. Patients complicated with active tuberculosis, malignant arrhythmia, acute myocardial infarction and stroke;
2. pregnant and lactating women;
3. Patients complicated with severe cognitive and mental disorders;
4. Clinical investigators who are participating in other interventions within one month prior to enrollment;
5. Those who are known to be allergic to therapeutic drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of PCR normalization;Clinical symptom score;
- Secondary Outcome Measures
Name Time Method Hospitalization time;Arterial blood gas;pneumonia severity index, PSI;SF-36;Chest imaging;28-day prognosis;84-day prognosis;EQ-5D;